Evidence map›Paper›PMID 39011527›Full record

ArticleIranian journal of parasitology

Evaluation of Nanonanoliposomal Curcumin on Cutaneous Leishmaniasis Skin Lesions Caused by

Sedigheh Shirmohammad, Mahdi Mohebali, Fatemeh Arabkhazaeli, Jalal Hassan, David Shayan, Narges Amininia, Parviz Shayan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sedigheh ShirmohammadIranian Research Center of Ticks and Tick-Borne Diseases, Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Iran.
Mahdi MohebaliDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh ArabkhazaeliIranian Research Center of Ticks and Tick-Borne Diseases, Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Iran.
Jalal HassanDepartment of Toxicology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
David ShayanInstitute Molecular Biological System Transfer (MBST), Tehran, Iran.
Narges AmininiaIranian Research Center of Ticks and Tick-Borne Diseases, Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Iran.
Parviz ShayanIranian Research Center of Ticks and Tick-Borne Diseases, Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Curcumin is an extract of rhizome turmeric (diferuloylmethane), with antioxidant, anti-inflammatory, antimicrobial, and anti-parasitic properties, which making it a potential candidate for the treatment of leishmaniasis. The aim of the presented study was to evaluate curcumin as possible candidate for treatment of cutaneous leishmaniasis. Methods: We investigated the physicochemical properties and anti-leishmanial effects of nanoliposomal curcumin (40, 80, and 120 μM) in Results: Treatment of Conclusion: Nanoliposomal curcumin could be considered as a potential drug against cutaneous leishmaniasis caused by

Indexed as

BALB/c miceCutaneous leishmaniasisLeishmania majorNanoliposomal curcuminSemi quantitative PCR

Identifiers

PMID39011527
PMCPMC11246207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.